Latest News and Press Releases

To Nasdaq Copenhagen FIXING OF COUPON RATES        5 May 2026 Fixing of coupon rates effective from 7 May 2026 Effective from 7 May 2026, the coupon rates of floating-rate bonds issued by Nykredit...

Vilnius, Lithuania, May 05, 2026 (GLOBE NEWSWIRE) -- As at the end of April 2026, the net asset value (NAV) of SUTNTIB AB Tewox decreased to EUR 44,329,408, compared to the previously determined...

Discure Technologies appoints Dr. Ray Baker to its Board of Directors, and fractional Chief Medical Officer, supporting the company onto its next stage.

Austin, May 05, 2026 (GLOBE NEWSWIRE) -- The Kaolin Market size was valued at USD 4.76 Billion in 2025 and is projected to reach USD 8.90 Billion by 2035, growing at a CAGR of 6.46% during the...

Neve Yarak, Israel, May 05, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS), (“Nexentis” or the “Company”), a drug discovery company that is also invests in solar energy assets...

Apptopia's Q1 2026 analysis for DKNG and FLUT reviews app performance and the competitive threat from Kalshi.

BRENTWOOD, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today...

As recently announced, tovecimig (DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement in progression-free survival (PFS)...

SAN DIEGO, May 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer,...

CAMBRIDGE, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing...